Neuroblastoma-targeted nanoparticles and novel nanotechnology-based treatment methods.

Luigi Cattel, Maurizio Ceruti, Franco Dosio, From conventional to stealth liposomes: a new frontier in cancer chemotherapy. Tumori. ,vol. 89, pp. 237- 249 ,(2003) , 10.1177/030089160308900302

Daniela Di Paolo, Fabio Pastorino, Chiara Brignole, Danilo Marimpietri, Monica Loi, Mirco Ponzoni, Gabriella Pagnan, Drug delivery systems: application of liposomal anti-tumor agents to neuroectodermal cancer treatment. Tumori. ,vol. 94, pp. 246- 253 ,(2008) , 10.1177/030089160809400217

Meng Zhang, Hai-Yan Fan, Sheng-Chao Li, Inhibition of c-Myc by 10058-F4 induces growth arrest and chemosensitivity in pancreatic ductal adenocarcinoma Biomedicine & Pharmacotherapy. ,vol. 73, pp. 123- 128 ,(2015) , 10.1016/J.BIOPHA.2015.05.019

Behdokht Bahrami, Mousa Mohammadnia-Afrouzi, Peyman Bakhshaei, Yaghoub Yazdani, Ghasem Ghalamfarsa, Mehdi Yousefi, Sanam Sadreddini, Farhad Jadidi-Niaragh, Mohammad Hojjat-Farsangi, Folate-conjugated nanoparticles as a potent therapeutic approach in targeted cancer therapy Tumor Biology. ,vol. 36, pp. 5727- 5742 ,(2015) , 10.1007/S13277-015-3706-6

Irene Cossu, Gianluca Bottoni, Monica Loi, Laura Emionite, Alice Bartolini, Daniela Di Paolo, Chiara Brignole, Francesca Piaggio, Patrizia Perri, Angelina Sacchi, Flavio Curnis, Maria Cristina Gagliani, Silvia Bruno, Cecilia Marini, Alessandro Gori, Renato Longhi, Daniele Murgia, Angela Rita Sementa, Michele Cilli, Carlo Tacchetti, Angelo Corti, Gianmario Sambuceti, Serena Marchiò, Mirco Ponzoni, Fabio Pastorino, Neuroblastoma-targeted nanocarriers improve drug delivery and penetration, delay tumor growth and abrogate metastatic diffusion Biomaterials. ,vol. 68, pp. 89- 99 ,(2015) , 10.1016/J.BIOMATERIALS.2015.07.054

Daniela Di Paolo, Monica Loi, Fabio Pastorino, Chiara Brignole, Danilo Marimpietri, Pamela Becherini, Irene Caffa, Alessia Zorzoli, Renato Longhi, Cristina Gagliani, Carlo Tacchetti, Angelo Corti, Theresa M. Allen, Mirco Ponzoni, Gabriella Pagnan, Chapter 12 Liposome-Mediated Therapy of Neuroblastoma Methods in Enzymology. ,vol. 465, pp. 225- 249 ,(2009) , 10.1016/S0076-6879(09)65012-6

Yasuhiro Oki, Michelle Fanale, Jorge Romaguera, Luis Fayad, Nathan Fowler, Amanda Copeland, Felipe Samaniego, Larry W. Kwak, Sattva Neelapu, Michael Wang, Lei Feng, Anas Younes, Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma. British Journal of Haematology. ,vol. 171, pp. 463- 470 ,(2015) , 10.1111/BJH.13603

Viola Baradari, Michael Höpfner, Alexander Huether, Detlef Schuppan, Hans Scherübl, Histone deacetylase inhibitor MS-275 alone or combined with bortezomib or sorafenib exhibits strong antiproliferative action in human cholangiocarcinoma cells World Journal of Gastroenterology. ,vol. 13, pp. 4458- 4466 ,(2007) , 10.3748/WJG.V13.I33.4458

Mark M Awad, Alice T Shaw, ALK Inhibitors in Non–Small Cell Lung Cancer: Crizotinib and Beyond Clinical advances in hematology & oncology. ,vol. 12, pp. 429- 439 ,(2014)

P L Garcia, A L Miller, K M Kreitzburg, L N Council, T L Gamblin, J D Christein, M J Heslin, J P Arnoletti, J H Richardson, D Chen, C A Hanna, S L Cramer, E S Yang, J Qi, J E Bradner, K J Yoon, The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic ductal adenocarcinoma in patient-derived xenograft models Oncogene. ,vol. 35, pp. 833- 845 ,(2016) , 10.1038/ONC.2015.126